Status:

RECRUITING

PULSED AF Post-Approval Study

Lead Sponsor:

Medtronic Cardiac Ablation Solutions

Conditions:

Atrial Fibrillation

Eligibility:

All Genders

18+ years

Brief Summary

PULSED AF PAS is a prospective, global, multi-center, non-randomized, observational trial. Subjects will be treated with the PulseSelect™ PFA System and followed through 36 months.

Detailed Description

PulseSelect is a prospective, global, multi-center, non-randomized, observational trial. Subjects will be treated with the PulseSelect™ PFA System and followed through 36 months. Study visits will occ...

Eligibility Criteria

Inclusion

  • Inclusion Criteria
  • A diagnosis of recurrent symptomatic paroxysmal AF or persistent AF
  • Refractory to at least one Class I or III antiarrhythmic drug (i.e., not effective, not tolerated, or not desired)
  • Patient is ≥ 18 years of age
  • Planned pulmonary vein isolation procedure with the commercially available PulseSelect™ PFA System
  • Willing and able to comply with study requirements and give informed consent (defined as legally effective, documented confirmation of a subject's voluntary agreement to participate in this clinical study) or authorization per institution and geographical requirements
  • Exclusion Criteria
  • Long-standing persistent AF (continuous AF sustained \>12 months)
  • Prior left atrial catheter or surgical ablation
  • Patient with life expectancy \< 36 months
  • Presence of a permanent pacemaker, biventricular pacemaker, loop recorder/insertable cardiac monitor (ICM), or any type of implantable cardiac defibrillator (with or without biventricular pacing function)
  • Current or anticipated participation in any other clinical trial of a drug, device, or biologic not approved by the global study manager

Exclusion

    Key Trial Info

    Start Date :

    November 4 2024

    Trial Type :

    OBSERVATIONAL

    Allocation :

    ESTIMATED

    End Date :

    June 1 2029

    Estimated Enrollment :

    580 Patients enrolled

    Trial Details

    Trial ID

    NCT06578104

    Start Date

    November 4 2024

    End Date

    June 1 2029

    Last Update

    November 14 2025

    Active Locations (14)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 4 (14 locations)

    1

    Pikeville Medical Center

    Whitesburg, Kentucky, United States, 41858-7428

    2

    Southcoast Health System

    Fall River, Massachusetts, United States, 02720

    3

    Beaumont Health System

    Royal Oak, Michigan, United States, 48073

    4

    Nebraska Medical Center

    Omaha, Nebraska, United States, 68198